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Crohn disease

A current perspective on genetics,
autophagy and immunity
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Crohn disease (CD) is a chronic and debilitating inflammatory condition of the gastrointestinal tract.1 Prevalence in western populations is 100–150/100,000 and somewhat higher in
Ashkenazi Jews. Peak incidence is in early adult life, although
any age can be affected and a majority of affected individuals progress to relapsing and chronic disease. Medical treatments rely significantly on empirical corticosteroid therapy
and immunosuppression, and intestinal resectional surgery
is frequently required. Thus, 80% of patients with CD come to
surgery for refractory disease or complications. It is hoped that
an improved understanding of pathogenic mechanisms, for
example by studying the genetic basis of CD and other forms
of inflammatory bowel diseases (IBD), will lead to improved
therapies and possibly preventative strategies in individuals
identified as being at risk.

10% dizygotics.2 The most widely accepted model is one in which
a genetically susceptible host encounters an environmental bacterial or viral agent, triggering a breach of the intestinal epithelial
barrier which separates the lumenal contents and microbial flora
from the mucosal immune system. This primary event may lead
to inflammatory flares in the gut mucosa. Subsequently, failures
to properly downregulate the immunological response and establish epithelial restitution and repair leave the gut primed for future
flare-ups, perhaps triggered by progressively less significant environmental insults. Crohn disease is characterized by discontinuous areas of inflammation in the distal small intestine and colon.
The distinguishing features of inflammation in CD are that it is
transmural and includes frequent lymphoid aggregates that are
present even in the outer muscle layer and mesothelial lining as
well as non-caseating granulomas composed of fused monocytederived cells. The transmural inflammation in CD is significant
as it is associated with fistula formation with adjacent tissues.
Features that distinguish ulcerative colitis (UC) include diffuse
inflammation mostly confined to the inner layer (the mucosa) of
the colon. The inflammation tends to be confluent and extends
proximally from the rectum to a varying degree throughout the
colon and is characterized by a complex mixture of inflammatory
cells. In the last decade substantial advances in the understanding
of the molecular pathogenesis of CD has been made as a result
of multiple related lines of investigation. Importantly, CD has
been one of the most tractable multigenic disorders for discovery
of susceptibility genes. The genetic associations identified in CD
suggest that multiple cell types and pathways are involved in generating the disease phenotype. These new discoveries have underscored the importance of epithelial barrier function, cell specific
microbial responses (autophagy, ER stress, phagocytosis), innate
(NOD proteins, inflammasome associated NALP3) and adaptive
immunity (IL23R/Th17 cells) in disease pathogenesis.
Early work in the study of IBD inflammation focused upon
alterations in the activation states of T cells (Th1, Th2 or more
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Introduction

Epidemiological evidence for a genetic contribution to CD is
clear-cut; 15% of patients with CD have an affected family member with IBD giving a relative risk to siblings of (λ)17x population
risk. In addition, twin studies for CD have shown approximately
50% concordance in monozygotic twins compared to less than
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recently Th17) and the resultant cytokine profiles that occur in
various forms of IBD. However, recent advances have focused on
the role of the innate immune system in initiating, modulating
and perhaps driving the abnormal inflammatory response that
occurs in IBD. Murine models of IBD have proved an important
tool to uncover the key pathways and innate cell types that play
a role in the pathogenesis/mucosal immunopathology of IBD.
In particular, efforts directed towards the identification of environmental factors implicate gut resident commensal microbiota
rather than pathogens as drivers of dysregulated immunity and
susceptibility to IBD. Commensal enteric bacteria are crucial
for development of the host immune system and intestinal epithelial cell repair and homeostasis,3-5 but they are also a critical
factor in determining the induction and the course of IBD as
indicated by the absence of colitis in several mouse IBD models
when they are derived as germ-free.6 In IBD patients, diversion
of the fecal stream is associated with improvement in CD7 and
some IBD patients improve upon intestinal washes or antibiotic
treatment.8-10 Alternatively, administration of probiotic bacteria
may contribute to the suppression of colitis.8,9 One theory of
IBD is that it involves dysregulation of the normal co-evolved
homeostatic relationships between the gut microbiota and the
host immune system. The identification of such perturbations
and how to effect their restoration is key to understanding the
pathogenesis of IBD and routes to therapy.
The intestinal microbiota is comprised of more than 1,000
species of bacteria, which in the colon reach densities of more
than 10,12 organisms per milliliter of lumenal content.11,12
Indeed, the lumenal contents of the colon account for 99.9%
of the known human indigenous microbiota.13 Indigenous
bacteria colonize mucosal surfaces and the gastrointestinal
tract at birth in a pattern that resembles ecological succession,14 which reaches climax early in childhood.13 The adult
microbiota for each individual is unique and stable over time,
as shown by culture-independent small subunit ribosomal
RNA gene-based assays.15,16
IBD patients have an altered lumenal- and mucosal-associated
microbiome, although the nature of the dysbiosis, and how this
relates to patient genotype, remains to be clearly defined. Of
interest, a number of groups have recently demonstrated increased
numbers of mucosal adherent-invasive E. coli (AIEC) in patients
with IBD. Strains of AIEC isolated from CD patients with ileal
disease induce epithelial injury and subsequent inflammation. In
addition, elegant studies from Garrett et al. have demonstrated
that enteric microflora grown in a strain of immunodeficient
mice (Tbet and Rag1 null) may transmit colitis to wild-type mice
through as-yet undefined microbes.17
Studies have implicated diminished levels of Faecalibacterium
prausnitzii as being associated with a higher risk of postoperative recurrence of ileal CD. Collectively, these studies underscore
the relevance of the host-microbial interaction in IBD and the
importance of achieving better definitions of these processes to
reach and understanding of the pathophysiology of these disorders. Despite the abundance of sensing and effector mechanisms
that are available to trigger inflammatory immune responses to
microbial intruders, the usual response to indigenous gut bacteria

is the induction of local and systemic tolerance, often characterized as oral tolerance.18 From this vantage point, one potential
model of IBD disease pathogenesis is that a dysregulated innate
immune response to intestinal microbes occurs in genetically susceptible individuals. Abnormal cytokine responses are features of
both CD and UC, although the model of CD as a T helper, Th1
driven illness and UC as a Th2 bias response now appears overly
simplistic with an emerging role imbalance between the Th17
lineage producing IL-23 and IL-17 and regulatory T/B cells in
both diseases.
In this review, experts in genetics, mucosal immunity and
autophagy provide an up-to-date perspective on Crohn disease.
Genome-Wide Association Studies Reveal
an Unexpected Role of Autophagy in Crohn Disease
The last three years have seen dramatic progress in understanding the genetic basis of CD and UC. This is due, in large part,
to comprehensive genetic studies of DNA samples from large
cohorts of patients and matched controls for over 300,000 genetic
variants spread across the human genome. These studies, known
as genome-wide association (GWA) studies, enable the examination of the majority of common genetic variation for roles in disease susceptibility. Given that the genetic variants tested in GWA
studies are spread throughout the genome, rather than selected to
test a specific set of genes, these studies have proven invaluable in
identifying biological pathways not previously suspected of playing a role in a disease’s pathogenesis. In the following sections, we
will recount how GWA studies have revealed a key role for autophagy in CD and place these discoveries in the broader context
of IBD genetics and pathophysiology.
For many years, investigators used affected sibling pair techniques of linkage analysis to try to localize IBD susceptibility
genes. Although limited by the intrinsically poor resolution of
this method for pinpointing individual genes, some success was
achieved using association-based methodologies to fine-map
within linkage intervals. The major success in CD, and indeed
one of the few successes across the spectrum of complex disease,
was the strong association identified with relatively rare variants
of the NOD2 gene. This flagged for the first time the importance
of defects in innate immunity as a key pathogenic mechanism
in IBD.
Nod2 is expressed intracellularly, particularly in monocytes
and Paneth cells, and encodes an intracellular receptor for muramyl dipeptide (MDP), a motif present in bacterial cell walls.
Although its exact function has yet to be determined, Nod2
appears to play an important role in innate immunity in modulating signaling through Toll-like receptor pathways and activating NFκB. Nod2 may also act as a sensor for intracellular
bacteria by triggering autophagy as they enter the cell.19,20 One
conundrum is that the NOD2 variants associated with CD result
in loss of function of the Nod2 protein, begging the question as
to how reduced activity of a key component of an innate immune
pathway can lead to an increase in inflammatory activity. Perhaps
the most plausible theories suggest that adaptive immune mechanisms may be recruited due to the defective innate immune
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pathways and that these might drive a physiologically “inappropriate” inflammatory response, but this has yet to be proven.
Recent years have seen a revolution in the ability of investigators to identify the genetic determinants of IBD and indeed all
complex diseases. Progress has been made possible by endeavors
such as the human genome project and advances in genotyping
technologies that make hypothesis-free methods of testing the
majority of the human genome for association with disease a tractable proposition. Such genome-wide association (GWA) studies
test hundreds of thousands of markers, known as single nucleotide polymorphisms (SNPs) in thousands of individuals, seeking markers at which there are statistically significant differences
in allele frequency between cases and controls. GWA studies are
being used across the spectrum of complex disease, but nowhere
has their application been more successful than in the field of
CD genetics.
Since late 2006, three high-density GWA studies and one
non-synonymous SNP scan have reported a total of 11 CD susceptibility loci, adding to NOD2 and OCTN/IBD5, previously
identified by fine mapping within linkage intervals. A subsequent
meta-analysis of GWA studies reported in 2008 brought to >30
the number of confirmed susceptibility loci for CD. These loci
have now been studied in large UC cohorts, which identified several loci that are shared between UC and CD, but also a number
of loci that are disease-specific.

mediating robust early immune control of intracellular bacterial
pathogens.30 Riol-Blanco and co-workers demonstrated that the
IL-23 receptor is vital for the maintenance of CD4 -, CD8- T cells
as well as γδ T cell populations, which provide early adaptive
immune responses to infection. These IL-17 producing effector
T cells are crucial for protection of mice against both L. monocytogenes and Francisella tularensis challenge. This extends the role
of IL-23 to protection against intracellular pathogens, as well as
differentiating inflammatory, auto-immune predisposing CD4 +
major histocompatibility complex (MHC) class II-restricted
Th17 cells, from their protective γδ or double-negative T cell
counterparts. This, along with the role of Th17 cells in organspecific inflammation, raises the hope that therapeutic disruption
of the IL-23 pathway will control auto-immune inflammation
without impairing systemic immunity.
Autophagy genes ATG16L1 and IRGM are specifically associated with CD. Association between the ATG16L1 (autophagyrelated 16-like 1) gene on 2q37.1 and CD was by identified by a
GWA study, as well as by an independent study of ~7,000 nonsynonymous SNPs.31 Both of these studies identified one amino
acid changing polymorphism (T300A, Ala197Thr, rs2241880)
within the ATG16L1 gene that was highly associated with CD,
a finding replicated in the index report and subsequently widely
elsewhere.26,32 Based on haplotype and regression analysis, this
variant was found to explain all the signals observed at the
ATG16L1 locus. It is not, however, associated with UC.25
Although the detailed functional impact of the Ala197Thr
variant remains unclear, it affects a highly conserved motif immediately adjacent to the part of the gene encoding the WD repeat
domain. Atg16L1 itself is known to play a key role in mammalian
autophagy,32 a process recognized as playing a role in both innate
and adaptive immunity. The Atg16L1 protein is widely expressed
not only in intestinal epithelial cells, but also in lymphocytes and
macrophages. Atg16L1 appears to play multiple roles related to
innate immunity, particularly in relationship to Nod proteins.
Both Nod1 and Nod2 were recently shown to direct Atg16L1
to bacterial entry sites on the plasma membrane, thus initiating
autophagy to remove invading pathogens.20 Initially, the authors
demonstrated that Nod agonists induce autophagy in human
and mouse cells. In mice, exposure to Nod1 or Nod2 ligands via
intraperitoneal injection following thioglycholate priming shows
Nod-dependent induction of autophagy within isolated macrophages. However, rapamycin or lipopolysaccharide (LPS) induction of autophagy is normal in cells isolated from either Nod1- or
Nod2-deficient animals. Using Shigella flexneri and Listeria
monocytogenes infection of mouse embryonic fibroblasts (wild
type or Nod1-deficient) Travassos and co-workers demonstrated
that autophagic control of both Shigella and Listeria infection
is dependent upon Nod1, but independent of RIP2 and NFκB.
The Nod proteins both immunoprecipitated with Atg16L1,
and a fraction of these proteins also co-located at the plasma
membrane when overexpressed, in a RIP2-independent manner.
Both endogenous and overexpressed Nod2 and AtgG16L1 (and
overexpressed Nod1) are observed to co-locate preferentially at
sites of bacterial entry following short periods of infection with
S. flexneri. However, the Nod2 association with Atg16L1 is
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Results from GWA Studies in IBD

The Th17 pathway is associated with CD and UC. In the
first reported GWA study of CD, variants in the interleukin 23
receptor gene (IL-23R) on chromosome 1p31 were found to be
unequivocally associated with CD susceptibility.21 The finding
was rapidly replicated and extended to confirming association
with UC.21,22 Perhaps surprisingly, a rare variant (Arg381Gln) in
the IL-23R gene was shown to confer protection against developing IBD, with multiple other IL-23R variants showing independent association. As with NOD2, association of IL-23R was not
seen in a well-powered CD association study from Japan.23
The importance of the IL-23 pathway has been further highlighted by the finding of association between variants in IL-12B,
which encodes the p40 subunit shared between IL-12 and IL-23,
and both CD and UC susceptibility.24-26 Most recently, the CD
meta-analysis highlighted a number of other components of the
Th17 pathway which are also associated with CD, including the
signal transducers STAT2 and JAK3, the chemokine receptor
CCR6 and co-stimulatory molecule ICOS-L27 (Table 1). STAT2
and JAK3 are also associated with UC.28
The IL-23/IL-12 pathway has become the subject of intensive study in the field of immunology as it plays a key role in
determining differentiation of naïve T cells into effector Th1
cells (driven by IL-12) or Th17 cells (driven by IL-23). Begum
et al.29 reported that specific bacterial components such as peptidoglycan can differentially induce antigen presenting cells
to produce IL-23 rather than IL-12, with this early regulatory
mechanism potentially leading to distinct patterns of inflammatory response. A recent paper has highlighted the role of IL23 in
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Table 1. Selected other IBD-associated loci
Locus

Proposed gene

Pathway

Other evidence

Cluster of SNPs 5.5 kb
upstream of PTPN2

PTPN2; T cell protein tyrosine
phosphatase (TCPTP)

Negative regulator of inflammatory
JAK-STAT signaling

Mouse knockouts show elevated IFNγ,
TNFα and IL-12243

ICOSLG

Inducible T-cell co-stimulator
ligand

Co-stimulatory molecule on antigen
presenting cells, key role in Th17 cells from
naïve CD4 lymphocytes27

STAT327

Signal transducer and
activator of transcription 3

Signal transduction in many cytokine
pathways including IL23 and IL6 and their
stimulation of Th17 cells244

JAK228

Janus kinase 2

One of the crucial kinases in the STAT3
pathway

CCR6

Chemokine (C-C motif)
receptor 6

G protein-coupled receptor expressed in
immature DCs and memory T cells,
mediates tissue-specific migration during
epithelial inflammation245

Recently shown to be expressed by Th17
cells in CD118

TNFSF1527,246

Tumor necrosis factor
superfamily, member 15

Induces NFκB activation, potentiates IL-2
signaling and secretion of IFNγ by
T lymphocytes.

Strongly associated with CD in Japan, more
modestly so in European populations;
known to be upregulated in CD247

NKX2-324-26

NK2 transcription factor
related, locus 3

Poorly characterized transcription factor
expressed in the intestine

Variants associated with CD and UC, the
former in Japanese as well as Europeans

27

Gene desert on chromosome 5p13

PTGER424,26,248

SNPs at 5p13 correlate with PTPGER4
expression

Encodes prostaglandin receptor EP4,
strongly implicated in mouse model of
IBD249

MST125,26,250

Macrophage stimulating 1

MST1 induces phagocytosis by resident
peritoneal macrophages

Variants associated with both UC and CD

ITLN127

Intelectin 1

ITLN1 recognizes galactofuranosyl residues
found in cell walls of various
microorganisms but not in mammals

Expressed in intestine, including in Paneth
cells, suggesting a role in innate
immunity251

ECM125

Extracellular matrix protein 1

Associated with UC in UK-based study, likely
due to altered intestinal permeability25

IL-10252,253

Interleukin 10

Variants associated with UC
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inhibited by the known CD-associated NOD2 frameshift mutation, resulting in impaired autophagy of invading S. flexneri and
reduced cytokine secretion in bone-marrow-derived macrophages
from transgenic mice expressing the CD-associated truncation.
In addition, the authors show that human cells homozygous for
the CD-associated ATG16L1 polymorphism (Ala197Thr) show
an impaired autophagic induction upon treatment with peptidoglycan or MDP (the Nod1 and 2 ligands, respectively), suggesting that Nod2 and Atg16L1 localization to the plasma membrane
is required for optimal innate immune signaling.
A related study sheds further light upon autophagy and the
role of ATG16L1 variants in stimulating innate immunity, and
thus driving adaptive immune responses to pathogens. Cooney
et al. demonstrated that both functional Nod2 and Atg16L1 are
required in dendritic cells (DCs) for the induction of autophagy
in response to Nod2 stimulation and proper induction of the
antigen-presentation and bacterial handling pathways.19 Unlike
in the epithelial and lymphoblastoid cells used by Travassos et
al. these effects in DCs are RIP2 dependent. However, the DC
system shows similar defects when CD-associated Nod2 and

358

IL-10 knock-out mice widely used as models
of IBD, colitis depends upon gut flora

Atg16L1 variants are studied, notably failure to induce autophagy
in response to MDP in the presence of either CD-predisposing
gene variant. In DCs this led to a failure to translocate bacteria to lysosomes, resulting in reduced bacterial killing. DCs in
which Atg5, 7 or 16L1 have been ablated via siRNA also failed to
relocate MHC class II to the cell surface following MDP stimulation. This is associated with loss of the localization of MHC
class II to autophagic compartments. In DCs from CD patients
with either CD-associated Nod2 or ATG16L1 variants, a similar
loss of MHC class II localization with the autophagic compartment is observed. Functionally, this results in curtailed antigen
presentation and an inability to generate CD4 + T cell responses
to bacterially-derived antigens following infection. These studies
demonstrate direct links between NOD2 frameshift variants and
autophagic bacterial control, as well as a novel Nod/autophagic
signaling axis. It will be of interest to see if, as well as colocalization of Atg16L1 and Nod proteins at the plasma membrane,
fully-formed autophagsomes provide a platform for Nod and
other pathogen-associated molecular pattern (PAMP)-mediated
signaling, via the delivery of recognition/ATG complexes to sites
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of autophagocytosed bacteria or by engulfing pathogen-derived
ligands and thus enhancing or turning off signaling.
Further emphasizing the importance of autophagy in CD
pathogenesis, the Wellcome Trust Case Control Consortium
(WTCCC) identified association between variants in another
key autophagy gene, immunity-related guanosine triphosphatase
(IRGM) and CD susceptibility. A panel of 2,000 CD cases and
3,000 controls was used in the index GWA scan, with replication
in an independent panel.24,33 Resequencing did not identify any
coding variants in IRGM, but subsequent work has shown the
associated variants to be in tight linkage disequilibrium with a
copy number variant 5' of IRGM and has demonstrated impact
on both gene expression and adverse impact on handling of intracellular bacteria.34
IRGM. In mice the interferon-induced Irg family contains
20 proteins, many of which are necessary for IFNγ mediated
resistance to intracellular pathogens.35-38 Two IRG orthologues
are found in humans, the widely expressed IRGM gene and the
testis-restricted IRGC gene. IRGM has a role in the autophagymediated destruction of Mycobacterium bovis BCG and Salmonella
typhimurium, in an expression dependent manner.34,36-38 In the
M. bovis BCG model of tuberculosis, IRGM-dependent clearance
of bacteria in macrophages is associated with IRGM localization
to bacteria-containing compartments. This feature is common to
both human IRGM and mouse IRGM1.36,37 Autophagy targeted
BCG vacuoles acquire lysosomal markers and the vacuole is acidified, suggesting fusion with the lysosome effects anti-bacterial
control.
Single nucleotide polymorphisms (SNPs) close to IRGM have
been strongly correlated with Crohn disease (CD) susceptibility in genome wide association studies (GWAS).24,32 A large 20
Kb deletion of potential regulatory sequence is in perfect linkage with the functional polymorphisms associated with CD.34
The regulation of IRGM in humans is complex. Different tissues and cell lines heterozygous for the two haplotypes (CD risk
and CD protective) express varying levels from each allele. In a
cell culture model of S. typhimurium infection decreased IRGM
expression significantly inhibits the efficiency of anti-bacterial
autophagy.34 It is possible that IRGM is regulated in a cell-type
specific manner and that altered expression induced by the CD
risk deletion may result in cell specific phenotypes.
The evolution of the IRG gene family also appears to have
been complex. A number of non-human primates, through
duplication and diversification events, have evolved up to 21
interferon-regulated genes. Sequenced prosimian lemur species
(Lemur catta and Microcebus murinus) have three IRG genes
clustered in a phylogenetically similar manner to mice. Through
study of Old World and New World monkeys, it appears that ~40
million years ago, IRGM became non-functional in a common
ancestor of these species and was resurrected ~20 million years
later in the common ancestor of humans and African great apes.39
The original loss of the gene is attributed to the integration of
an Alu repeat disrupting the ORF. The restoration of the ORF
coincides with the integration of an ERV9 element. Said element
serves as a functional promoter for the human IRGM gene, suggesting that alterations of the gene expression are retroposon

induced. Interestingly, orangutans and gibbons possess both
functional and non-functional IRGM alleles. It seems that the
locus is continuing to evolve in humans, possibly reflecting our
ever-changing relationship with intracellular pathogens.
The emerging evidence would suggest that dysregulation of
autophagy genes may contribute to the pathogenesis of inflammatory bowel disease via several routes: through Atg5 mediated
removal of autoreactive CD4 + T cells; through Atg16L1-mediated
endotoxin-induced inflammatory signaling in macrophages and
Paneth cells, and potentially via autophagy related lymphocyte
homeostasis. Each of these will be further explored in subsequent
sections of this review. Much remains to be done to elucidate the
precise mechanisms of ATG16L1 and IRGM polymorphisms in
the pathogenesis of Crohn disease, but autophagy appears to be
paramount to the mucosal immune system.
GWA studies have thus yielded many important insights
into IBD pathogenic mechanisms, particularly relating to the
roles of the Th17 pathway and innate immunity (particularly
autophagy), but a number of surprises and challenges have also
revealed themselves. It is evident that nearly all of the susceptibility loci identified individually confers only a modest increase risk
and that, despite having identified >30 CD susceptibility genes,
only ~20% of the genetic variance has yet been accounted for.
Characterizing the remainder is one of the major future goals for
IBD geneticists.
In addition, for the majority of loci the associated SNPs are
simply markers and the true causal variant(s) have yet to be
identified. The methodologies for such fine-mapping have yet
to be fully worked out. Further hindering functional studies is
that the cellular targets for a given IBD-predisposing variant
are still unclear for most genes. A further confounding factor
is that many causal variants appear to be non-coding,27 most
likely predisposing to IBD as a consequence of their impact on
the regulation of gene transcription. Indeed, nearly a third of
the confirmed loci lie in so-called “gene-deserts”. Determining
exactly how each of these affect transcriptional regulation will
challenge biologists beyond the IBD community, and may have
far-reaching implications for our understanding of genetics in a
broader sense.

©201
1L
andesBi
os
c
i
enc
e.
Donotdi
s
t
r
i
but
e.

www.landesbioscience.com

Autophagy and the Role of Atg16L1—
From Yeast to Mammals
Autophagy was first identified as a starvation response in yeast,
and the yeast system remains the best studied and characterized,
despite considerable recent efforts in other models. It has been
assumed that yeast represents the ancestral system, with mammalian autophagy exhibiting increased complexity and regulation. Molecular and genetic evidence suggest that the role of
autophagy in multicellular organisms extends beyond starvation
responses and has an impact upon other stress-induced pathways,
as well as playing tissue-specific roles in the immune response.
However, the core functions and apparatus remain conserved
from yeast, forming a bulk degradation system, which maintains
cellular homeostasis. In concert with the proteasome, autophagy
degrades and recycles cellular components, reducing cellular
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Atg8, is conjugated to the head group of
phosphatidylethanolamine (PE) through
an amide bond, which is mediated by
Atg4 (a C-terminal processing enzyme),
Atg7 and Atg3 (E2-like enzyme).45,46
These two conjugation systems are
highly conserved in eukaryotes.47,48 In
mammals, Atg8 homologs consist of three
distinct families: the LC3, GABARAP
and GATE-16 families. All of them can
be conjugated to PE and localized on autophagosome membranes.49,50 The Atg12
system is also conserved. Atg12 is conjugated to Lys130 of Atg5 in mammals.51
The mammalian Atg12–Atg5 conjugate is
multimerized by Atg16L1 (a mammalian
Atg16 homolog) to form a large complex,
which is estimated to be 800 kDa based
on gel filtration experiments.47 It should
be noted that the structures of yeast Atg16
and Atg16L1 are quite different. Atg16L1
of various higher eukaryotes including mammals has a large C-terminal
Figure 1. Biochemical features of Atg16L1 and its related proteins. (A) The Atg8/LC3 and Atg12
WD repeat domain in addition to the
conjugation systems. In the Atg8/LC3 conjugation system, the C-terminal arginine (this C-terminal
N-terminal Atg16-like region (Fig. 1B).
extension is much longer in human and mouse) is first cleaved off by Atg4 to expose the glycine
residue. Atg8/LC3 is then activated by Atg7, transferred to Atg3 and finally conjugated with PE.
Since the WD repeat domain is involved
Atg8/LC3–PE is deconjugated again by Atg4. In the Atg12 system, Atg12 is activated by Atg7, transin protein-protein interactions, there may
ferred to Atg10 and then conjugated to Atg5. Atg12–Atg5 is multimerized by Atg16(L). (B) Yeast
be an unidentified factor(s) interacting
Atg16 and human Atg16L1 structures. The coiled-coil domain and C-terminal WD repeat domains
with Atg16L1 through this domain. This
are shown. Binding sites of interacting partners are also indicated.
WD domain may be important for regulation or specific subtypes of autophagy,
stress and maintaining an amino acid pool essential for survival perhaps in response to pathogen infection.52 Mice deficient in
during periods of starvation.3-5 Autophagy operates through the Atg3, 5, 7 and 16L die within one day after birth,53-56 apparently
encapsulation of organelles and cytoplasm within a membrane- unable to transition from placental to intermittent oral nutrition.
bound organelle, termed the autophagosome. The apparatus Autophagosome formation is defective in cells derived from these
used to create this unique structure is outlined below.
knockout mice, suggesting that these two conjugation systems
Yeast genetic analyses have thus far identified 34 autophagy- are essential for autophagy in mammals.
related (ATG) genes.40,41 Among these genes, ATG1-10, 12–14,
An in vitro reconstitution experiment revealed that the
16–18, 29 and 31 are required for autophagosome forma- yeast Atg12–Atg5 conjugate interacts with Atg3 and facilitates
tion.41,42 These gene products are classified into five functional Atg8–PE conjugation.57 Atg8–PE and LC3–PE conjugation
groups: (1) the Atg1 protein kinase complex, (2) the Atg14- are also severely affected in vivo both in yeast and mammalian
phosphatidylinositol 3-kinase complex, (3) the Atg2-Atg18-Atg9 cells defective in the Atg12 conjugation system.55,58,59 Thus, the
complex, (4) the Atg12 conjugation system and (5) the Atg8 con- Atg12–Atg5 conjugate behaves as if it is an E3-like enzyme in the
jugation system.41
Atg8/LC3 conjugation system. In contrast, Atg16 is not essenBoth the Atg12 and Atg8 conjugation systems are ubiquitin- tial for Atg8–PE formation, at least in yeast,59 and therefore, the
like systems, which are thought to be involved in the elongation Atg12–Atg5-Atg16 complex must have some function other than
step of the phagophore membrane (Fig. 1A). Atg12, a ubiquitin- simple catalysis of the Atg8–PE conjugation. One possible funclike protein, is conjugated to Lys149 of Atg5 through an isopep- tion is recruitment of Atg8 to the phagophore to form Atg8–PE.
tide bond.43 This conjugation reaction is mediated by Atg7 (an If Atg12–Atg5-Atg16L1 is artificially expressed on the plasma
E1-like enzyme) and Atg10 (an E2-like enzyme). The resulting membrane in mammalian cells, LC3 can be lipidated on this
Atg12–Atg5 conjugate (en dash is used to denote a covalent link- membrane.60 Another interesting observation is that Atg16L1
age) is multimerized by Atg16.44 Atg16 is a 150-amino acid pro- can interact with Rab33B in a GTP-dependent manner and this
tein that contains an Atg5-interacting domain and a coiled-coil interaction is important to promote autophagy.61 Rab33B is a
domain at its N and C terminus, respectively (Fig. 1B). Atg16 Golgi-resident protein, but is partially redistributed to the phagoforms a dimer through the coiled-coil domain, thereby cross-link- phore under starvation conditions. Thus, Rab33B may regulate
ing the Atg12–Atg5 conjugates. Another ubiquitin-like protein, autophagy through interaction with Atg16L1.
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The physiological role of Atg8/LC3 also remains incompletely
understood. It has been demonstrated that Atg8–PE can be oligomerized and induces membrane hemifusion in vitro.62 Although
this function could be physiologically relevant, it is unknown
whether autophagosome formation indeed requires membrane
hemifusion. Another yeast study demonstrates that the Atg8
expression level regulates the size of autophagosomes.63 Although
its mechanism is unknown, it may be related to a recent finding that human Atg3 interacts with FNBP1L, a human ortholog
of yeast Bzz1.64 FNBP1L and Bzz1 contain an F-BAR domain,
which is involved in generating membrane curvature generation.
FNBP1L is dispensable for canonical autophagy, but is essential
for autophagy of intracellular Salmonella. Besides the proposed
role of Atg8/LC3 in membrane elongation, it may also be important for completion of autophagosome formation. Unclosed autophagosomes accumulate in Atg3-deficient fibroblasts56 and cells
expressing a dominant negative Atg4B (Atg4BC74A).65 These phenotypes may be interpreted as the result of inappropriate elongation of the phagophore membrane. Overall, Atg12–Atg5-Atg16L
and Atg8/LC3–PE are important for proper elongation and possibly for completion of the phagophore membrane.
APG15 is identical to APG16. The term ATG is a unified
name of several autophagy-related gene collections such as APG,
AUT, CVT, GSA, PAZ and PDD.66 The initial screen for autophagy defective mutants performed by Y. Ohsumi’s group isolated
15 apg mutants (apg1-apg15).67 Later, apg7 and apg11 were determined to be allelic.68 In 1999, another novel APG gene was identified by a yeast two-hybrid screen using Apg12 as bait.44 At that
time, APG2 and APG15 had not yet been cloned. When a yeast
strain deficient for this novel gene was mated with either mutant
apg2-1 or apg15-1, autophagy deficiency was restored. This
complementation test indicated that this novel gene was neither
APG2 nor APG15 and it was named APG16.44 However, cloning
of the APG15 gene revealed that it was identical to APG16 and
apg15-1 was a nonsense (UGA) mutation of the 83rd CGA codon
(arginine) of APG16.69 This result was very surprising because
a diploid strain generated by mating of apg15-1 and apg16Δ
strains showed normal autophagic activity.44 Further detailed
analysis revealed that this discrepancy was due to the strain background used in the mating experiment. A [PSI +]-like cytoplasmic
omnipotent suppressor was present in the apg16Δ strain, which
decreased translational fidelity and caused misreading of the
nonsense mutation in the apg15-1 allele.69 As a result, the phenotype of the apg15-1 allele was partially suppressed. Although the
precise nature of this cytoplasmic suppressor remains unknown,
it seems to be widely distributed in laboratory yeast strains, but
not in the one used in the apg mutant screening. Therefore, the
original apg15-1 mutant shows a complete autophagy-defective
phenotype. Now, ATG11 and ATG15 are the gene names assigned
to the previously named CVT9/GSA9/PAZ6/PDD18 and AUT5/
CVT17 genes, respectively.

has been suggested to be involved in the regulation of inflammation,31,32,72-74 yet the mechanisms underlying the suppression
of inflammatory responses by autophagy are poorly understood.
Recently, the Akira laboratory generated ATG16L1-deficient
mice and demonstrated that Atg16L1 is essential for autophagosome formation, with most knockout mice dying within a day of
birth.55 Therefore studies have utilized Atg16L1-deficient murine
embryonic fibroblasts and macrophages, as well as chimeras lacking ATG16L1 expression in specific cell lineages to elucidate the
role of Atg16L1 and autophagy in innate immune responses.
Enhanced endotoxin-induced IL-1β production by Atg16L1Deficient macrophages. Toll-like receptors (TLRs) are a family
of pattern recognition receptors that target microbial components and play a critical role in the innate immune response.75
Aberrant activation of TLR signaling pathways, often induced by
disruption of the negative regulatory machinery, results in massive inflammation and may cause septic shock or autoimmune
disease.70,75 Therefore, Saitoh et al. attempted to identify the role
of Atg16L1 in TLR-mediated innate immune responses, particularly the LPS-induced production of inflammatory cytokines,
such as TNFα, IL-6 and IL-1β.55 Although the involvement
of autophagy-related proteins in the TLR-mediated antiviral
response and in phagocytosis has been reported, it is unclear
whether Atg16L1 regulates the production of inflammatory cytokines induced by TLR engagement.76,77 Although the production
of TNFα and IL-6 was almost normal in Atg16L1-deficient
macrophages, IL-1β production was enhanced compared with
that in wild-type macrophages (Fig. 2A).55 Synthetic lipid A, an
active component of LPS, also potently induced IL-1β production in Atg16L1-deficient cells. In addition, non-invasive Gramnegative bacteria, such as Enterobacter aerogenes, Escherichia
coli and Klebsiella pneumoniae (all found in the commensal
flora), potently induced IL-1β production by Atg16L1 deficient
macrophages.55
Basal autophagy, but not stimulation-induced autophagy,
regulates IL-1β production. An important question is whether
enhanced IL-1β production results from Atg16L1 deficiency per
se or autophagy deficiency in general. To address this Saitoh
et al. used mutant mice deficient in Atg7, another essential
autophagy protein.53 Like Atg16L1-deficient macrophages, Atg7
deficient macrophages show increased production of IL-1β, suggesting that the disruption of autophagy is responsible for the
phenotype.
There is increasing evidence that basal autophagy plays an
important role under pathophysiological conditions like the
immune response, neurodegeneration and hepatic dysfunction.76,78-80 Recently, the potential involvement of TLR signaling in the induction of autophagy has been reported.81,82 In
contrast to previous reports, LPS stimulation does not increase
the number of endogenous LC3 puncta in mouse primary macrophages.55 However, infection with Salmonella typhimurium,
an invasive Gram-negative bacterium, results in Atg16L1dependent formation of bacteria-containing autophagosomes
in macrophages.55 The formation of these autophagosomes does
not require engagement of TLRs, since it occurrs in the absence
of both MyD88 and TRIF, both essential adaptor molecules for
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The Impact of Autophagy upon Inflammation
In mammals, systems for protein degradation are critical for tight
control of the inflammatory immune response.70,71 Autophagy
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Figure 2. Autophagy suppresses endotoxin-induced inflammatory immune responses. (A) TLR4 triggers both MyD88- and TRIF-dependent signaling
pathways in response to LPS. The IKKα-IKKβ-NEMO complex mediates the activation of the transcription factor NFκB which, in turn, induces transcription of pro-inflammatory cytokines, such as TNFα, IL-6 and pro-IL-1β. The TBK1-IKK-i complex mediates the activation of the transcription factor IRF-3,
which then induces the transcription of Type I IFN and IFN-inducible genes. In autophagy-deficient cells, high levels of ROS are generated and mediate
TRIF-dependent caspase-1 activation resulting in the production of IL-1β. However, in wild-type macrophages, limited amounts of IL-1β are induced by
LPS due to a lack of ROS generation. (B) Hypothetical model of intestinal inflammation caused by autophagy deficiency. The intestinal epithelial layer
lacking autophagy seems to be susceptible to microbial infection due to the disrupted maturation of Paneth cells. The barrier function of intestinal
epithelial cells is also compromised by chemical stress such as DSS exposure resulting in the invasion of commensal bacteria. Macrophages and
dendritic cells detect invading bacteria and produce inflammatory cytokines. Autophagy-deficient macrophages produce high levels of IL-1β and IL-18
leading to severe inflammation mediated by lymphocytes.

TLR signaling pathways.55,75 The failure of autophagy induction
by TLR signaling suggests that inhibition of basal autophagy
induces IL-1β overproduction by the macrophages stimulated
with endotoxin.
Enhanced TRIF-dependent caspase-1 activation by disruption of Atg16L1. Another question concerns the molecular
mechanism underlying enhanced endotoxin-induced IL-1β production in Atg16L1-deficient macrophages. The expression of
both IL-1β mRNA and immature pro-IL-1β protein following
LPS stimulation of Atg16L1 deficient macrophages was almost
comparable with that seen in wild-type cells, indicating an abnormality in post-translational regulation.55 In Atg16L1-deficient
macrophages, LPS stimulation induces the cleavage of caspase-1
to an activated form, which mediates the processing of pro-IL-1β
to mature IL-1β (Fig. 2A).83,84 IL-18 production, which is mediated by caspase-1, is also enhanced in Atg16L1-deficient macrophages stimulated with LPS. The activation of NFκB and p38
signaling pathways by LPS is similar in wild-type and Atg16L1deficient macrophages, suggesting that the enhanced IL-1β production in Atg16 deficient cells is not due to disruption of these
signaling pathways.55
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Among the TLR family members, TLR2, TLR4 and TLR5
detect bacterial components and are required for the antibacterial immune response.75 The Akira group found that the ligand
for TLR4, but not the ligands for TLR2 or TLR5, induced IL-1β
production by Atg16L1 deficient macrophages.8 These findings
prompted them to assess the involvement of TRIF signaling,
which is selectively initiated by the engagement of TLR4 on
macrophages.75 They generated Atg16L1-TRIF double-deficient
mice and found that Atg16L1-TRIF double-deficient macrophages failed to produce IL-1β in response to LPS stimulation
because of a lack of caspase-1 activation (Fig. 2A).55 The addition
of IFNβ or IFNγ enhances TLR2-mediated IL-1β production
by Atg16L1 deficient macrophages.8 These results indicate that
disruption of Atg16L1 in macrophages causes enhanced LPSinduced IL-1β production in a TRIF-IFN-dependent manner.
Elevated levels of reactive oxygen species in Atg16L1deficient macrophages. Recent studies have shown that ROS
play an important role in the activation of caspase-1 induced by
ATP, uric acid crystals, silicas and asbestos.83,84 Therefore, the
potential involvement of ROS in the enhanced IL-1β production by Atg16L1-deficient macrophages was assessed. Strikingly,
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the enhanced IL-1β production from Atg16L1-deficient macrophages is blocked by the ROS scavengers N-acetyl-L-cysteine and
FeTPPS (Fig. 2A).55 Also, the level of ROS in LPS-stimulated
Atg16L1-deficient macrophages is higher than that in Atg16L1TRIF double-deficient or wild-type macrophages. These results
suggest that ROS accumulate in Atg16L1-deficient macrophages
following LPS stimulation and induce TRIF-dependent production of IL-1β.
Severe dextran sulphate sodium-induced colitis in chimeric
mice lacking Atg16L1 in hematopoietic cells. Elevated expression of IL-1β and IL-18 is involved in the development of intestinal inflammation,85,86 and recent studies have reported that
Atg16L1 is a candidate susceptibility gene for Crohn disease.31,32
This led to the question as to whether Atg16L1 is involved in
the development of colitis. Atg16L1-deficient chimeric mice do
not develop spontaneous colitis and that the large intestines of
newborn Atg16L1-deficient mice are not inflamed. The number
of bacteria in the feces of wild-type or Atg16L1-deficient chimeric
mice is similar with no bacteria detectable in the spleens of these
animals.55
A corollary question was whether Atg16L1 deficiency exacerbated inflammation in a dextran sulphate sodium (DSS)-induced
experimental model of colitis. Strikingly, chimeric mice lacking
Atg16L1 in hematopoietic cells died following severe weight
loss after DSS treatment (Fig. 2B).55 Control chimeric mice
expressing wild-type Atg16L1 in hematopoietic cells survived.
Intraperitoneal administration of 3-methyladenine, an autophagy
inhibitor, increases the levels of IL-1β in serum and reduces the
survival rate of mice treated with DSS. This suggests that autophagy protects mice from intestinal inflammation. Histological
analysis reveals a more severe inflammation in the distal colons of
Atg16L1-deficient mice than that seen in control mice with larger
areas of ulceration and increased infiltration of lymphocytes. The
levels of the pro-inflammatory cytokines IL-1β and IL-18 are significantly elevated in the sera of DSS-treated Atg16L1-deficient
chimeric mice relative to controls. Mortality and loss of body
weight after DSS exposure in Atg16L1-deficient chimeric mice
are reduced by the injection of anti-IL-1β and anti-IL-18 antibodies, thus demonstrating the involvement of excessive production of these cytokines in the development of severe colitis.55
Remaining issues. These studies highlight a novel role for
autophagy in the regulation of the inflammatory immune
response. Disruption of autophagy causes TRIF-dependent elevation of ROS in LPS-stimulated macrophages.55 Accumulated
ROS causes inflammasome activation leading to the production
of the inflammatory cytokines IL-1 and IL-18. The source of this
ROS has not been identified; however, Tcshopp and colleagues
have reported that NADPH oxidase-induced ROS generation is
required for the activation of caspase-1 as well as for the production of IL-1β by stimuli such as ATP, uric acid crystals, silica and
asbestos.84 However, NADPH oxidase seems not to be involved
in the accumulation of ROS in autophagy-deficient macrophages because inhibitors of NADPH oxidase fail to suppress
LPS-induced IL-1β production by these cells (Tatsuya Saitoh
and Shizuo Akira unpublished data). Other possible sources of
ROS include mitochondria. Recent studies clearly demonstrate

that autophagy is required for the maintenance of mitochondrial
homeostasis and that targeted disruption of the autophagy-related
genes results in the accumulation of ROS in immune cells.87,88 S.
Akira and colleagues are currently investigating whether mitochondrial ROS are involved in IL-1β production by Atg16L1deficient macrophages.
The Nod-like receptor (NLR) family members, IPAF and
NALP3 have been well studied; they each form a complex called
an inflammasome with an adaptor molecule, ASC, which activates caspase-1, resulting in the production of IL-1β.83,84 The
IPAF inflammasome, which detects the protein flagellin on S.
typhimurium, mediates both IL-1β production and caspase-1-induced cell death and is essential for host defense. The NALP3
inflammasome detects a variety of stimulatory molecules such
as ATP, uric acid crystals, silica and asbestos, and plays a major
role in the induction of inflammation by regulating caspase-1
activation.83,84 LPS-primed Atg16L1-deficient macrophages produce high levels of IL-1β following stimulation by ATP or uric
acid crystals, both stimulators of the NALP3 inflammasome.
However, the production of IL-1β induced by S. typhimurium
mediated by the IPAF inflammasome shows little elevation in
LPS-primed Atg16L1-deficient macrophages.55 Although caspase-1 activation is critical for LPS-induced IL-1β production by
autophagy-deficient macrophages, the NLRs responsible for the
activation of caspase-1 in autophagy-deficient cells have not been
identified. Therefore, current investigations are concentrating on
whether activation of the NALP3 inflammasome is required for
IL-1β production by Atg16L1-deficient macrophages, and also
whether activation of the NALP3 inflammasome is involved
in the intestinal inflammation induced by Atg16L1 deficiency.
The role of NOD2, another NLR implicated in CD, has also
been examined in ATG16L1-deificient cells. Atg16L1 deficient
macrophages produced the inflammatory cytokines IL-1β and
IL-6 in response to MDP, a ligand for Nod2,55 indicating that
Atg16L1 is not required for Nod2-mediated signaling of cytokine
production. However, it is still unclear whether the detection of
invading microbes by Nod2 or other NLRs induces Atg16L1dependent autophagosome formation. Further experiments using
mutant mice lacking NLRs are needed to address this issue.
In conclusion, Atg16L1 regulates the endotoxin-induced
inflammatory response. Given the importance of the elevated
expression of IL-1β and IL-18 caused by Atg16L1 deficiency in
the pathogenesis of mouse model of colitis, it would be of interest
to assess the role of both autophagy and inflammasomes in the
development of inflammatory bowel disease in humans.
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Autophagy and IBD Immunity—
The Adaptive Immune System
While the link between autophagy and innate immunity is
being elucidated through recent studies, there remains a substantial gap in our knowledge of the role of autophagy in the
adaptive immune system. Key players in linking innate and
adaptive immune responses are antigen-presenting cells (APCs),
which are capable of presenting both exogenous (e.g., bacteria)
and endogenous (self) antigens to T cells for activating adaptive
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immune responses. Autophagy plays a critical role in the MHC
class II-dependent antigen presentation to CD4 + T cells. Indeed,
impaired autophagy in a specific APC in the thymus results in
the development of colitis.89 In addition, autophagy in T cells
per se is implicated in their survival and proliferation.90 Once
effector immune responses are generated, regulatory immune
cells expand to prevent the responding effector cells from causing harmful effects. Autophagy may directly or indirectly participate in the differentiation of several regulatory (T and B) cell
subsets. Therefore, autophagy is required for the entire immune
processes involved in the pathogenesis of IBD through controlling the function and development of many different cell subsets
in the intestine.91 In this section, we discuss the potential role of
autophagy in CD-associated adaptive immune responses.
Antigen sampling by dendritic cells. Bacteria are processed
by APCs capable of presenting the antigen to T cells. Dendritic
cells (DCs) are professional APCs that can capture enteric bacteria that have invaded the intestinal mucosa by breaching the
epithelial barrier. They can also sample the bacteria present in the
intestinal lumen by extending dendrites directly into the lumen
or by interacting with a specialized epithelial cell termed M cells
and through neonatal Fc receptor (FcRn)-dependent transport
of IgG/bacterial antigen complexes across the epithelial layer.92,93
Intestinal DCs provide a significant contribution to the direct
linkage between innate and adaptive immune responses. There
are several DC subsets in the intestine, which play different roles
in the pathogenesis of IBD.92 Some DC subsets, particularly
those expressing CD103, maintain tolerance towards commensal enteric microorganisms, whereas others are implicated in the
generation of effector immune responses against potential pathogens.92 A unique DC subset that shares some phenotypic and
functional features with macrophages increases in the inflamed
colon of CD patients and in the intestinal granulomas of a mouse
CD model.94,95 This unique DC subset is able to produce large
amounts of IL-23 in response to bacterial products. In addition, local factors present in the intestine, such as thymic stromal lymphopoietin (TSLP) and retinoic acid, further condition
the function of intestinal DCs.92,94,96 Bacteria-derived adenosine
5'-triphosphate (ATP) also activates a unique CD70highCD11low
APC to enhance the differentiation of the Th17 subset.97
Involvement of autophagy in DC function has become increasingly apparent. Autophagy is required for the recognition of virus
by plasmacytoid DCs76 and it also enhances the antigen presentation by DCs facilitating the efficacy of vaccination.98 However, it
is largely unknown whether autophagy plays a role in the intestinal DC function involved in the pathogenesis of IBD. Therefore
it is likely that autophagy plays a major role in facilitating and
controlling antigen presentation and immune activation in the
gut compartment, in both healthy and diseased states.
Effector immune responses. Cellular degradation systems
such as proteasomes and lysosomes are used not only for the
elimination of intracellular bacteria but also influence adaptive
immune responses. Autophagosomes can engulf cytosolic components and thereby deliver cellular and microbial degradation
products to MHC class II compartments. This was first suspected during experiments in the early 1990s showing that APCs

can process cytoplasmic influenza and measles virus proteins for
presentation by MHC class II.99,100 This requires lysosome acidification, but does not require TAP transporters or protein trafficking through the Golgi apparatus, suggesting direct delivery
of proteins to lysosomes from the cytosol. This model is consistent with biochemical studies showing that some 35% of peptides
bound to HLA-DR molecules are derived from nuclear or cytosolic proteins101 and that the percentage rises following induction
of autophagy by starvation. Autophagy also causes downregulation of lysosomal cathepsins and altered patterns of peptide processing, suggesting that autophagy has the potential to change
the nature of peptides presented to CD4 + T cells. Recent studies
show that autophagosomes labeled with GFP-LC3 fuse directly
with MHC class II compartments in both epithelial cells and
professional APCs and that LC3 is delivered constitutively to
lysosomes over many hours.102,103 Constitutive autophagy is also
evident in transgenic mice expressing GFP-LC3 where autophagosomes are seen in tissues in the absence of starvation.104
Autophagy can also deliver model antigens into class II antigen
processing pathways if they are targeted to autophagosomes by
fusion to LC3. Presentation of fusion proteins to T cells is lost
if the lipidation motif in LC3 is mutated to prevent attachment
to autophagosomes, or following ATG12 silencing.103 Parallel
studies80 have argued that autophagosome processing of proteins
for presentation by MHC class II should show a preference for
long-lived proteins. This proved correct for lymphoblastic cells
infected with Epstein-Barr virus where the long-lived nuclear
antigen EBNA1 was presented to CD4 + T cells through a pathway that was blocked by silencing ATG12. In the same study a
short-lived EBNA1 lacking the sequences that prevent degradation by the proteasome was presented by MHC class I rather than
class II.
The evidence that autophagy delivers cytosolic proteins for
processing and presentation to CD4 + T cells by MHC class II
is now very strong. Autophagy may be particularly important
for intestinal epithelial cells that are not actively endocytic and
where class II antigen expression increases in an inflammatory
setting in response to INFγ. Interestingly, INFγ? does not generate greater numbers of autophagosomes. The increased capacity
to present antigens in response to INFγ results from increased
MHC class II expression coupled with increased delivery of LC3
positive autophagosomes to MHC class II compartments.103 For
an overview of current concepts in the relationship between
autophagy and phagocytosis see refs. 105, 106.
In addition to the involvement of autophagy in antigen-presentation that is required for initiating adaptive immune responses,
autophagy provides significant contributions to immune regulation through its role in proliferation and survival of T cells
after T cell receptor (TCR) ligation. Double-membrane autophagosomes can form in both human and murine T cells and
autophagy enhances the survival and proliferation of memory
T cells through clearance of superfluous mitochondria.87,89,90,107
Contributions of dysregulated homeostasis of memory T cells
have been implicated in the pathogenesis of colitis. Indeed,
implantation of Atg5-deficient thymus induces the development
of systemic inflammations, including colitis, in the recipient
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athymic mice, suggesting the requirement of autophagy for the
appropriate selection of self antigen-specific CD4 + T cells.89
The antigenic responses of CD4 + T cells are determined by the
diversity of the T cell receptor (TCR) repertoire. In both human
IBD and experimental models, the TCR repertoire utilized by
intestinal CD4 + T cells is sharply skewed, suggesting antigenspecific activation of effector CD4 + T cells.108 Antigens present in
high-levels in the gut compartment include bacteria-derived flagellins, which have been demonstrated to serve as IBD-associated
antigens capable of stimulating Th1 and Th17 responses.109
In addition to exogenous antigen presentation, a major function of autophagy is the regulation of self-responses.110 Autophagy
contributes to the clearance of apoptotic cells that represent the
major source of self antigens.111 The role of autophagy in selfresponses recalls past findings in IBD models where the involvement of impaired clearance of apoptotic cells has been proposed
to exacerbate chronic colitis.112 In addition, commensal bacteria
are required for exacerbation, but not development, of ileitis in
the SAMP1/YitFc mice, a model of CD.113 These observations
raise the possibility that autophagy plays critical roles in the recognition not only of exogenous antigens, but also for self antigens
in IBD.
Th1 responses have been implicated in the pathogenesis of
CD, whereas UC has a significant contribution from Th2 cytokines such as IL-4, IL-5 and IL-13.114 In addition to the Th1/
Th2 theory, recent accumulating studies have unveiled a critical involvement of the IL-23/Th17 pathway in the pathogenesis
of IBD.115 IL-12p70 (p40/p35) has generally been believed to be
a crucial factor involved in the development of CD because of
the beneficial effect of anti-IL-12p40 treatment on CD patients
and experimental models.114 However, it is becoming increasingly apparent that IL-23 (a heterodimer of p40 and p19 subunits) rather than IL12 (a heterodimer of p40 and p35 subunits)
contributes to the development of CD.115 Indeed, IL-23 receptor
polymorphisms are negatively associated with the development of
IBD.21 IL-23 serves to maintain a Th17 subset that is characterized by the production of IL-17 (IL17A), IL-17F, IL-21, IL-22
and IL-26, but not IFNγ or IL-4.116 An intestine-specific Th17
subset expressing CD161 has recently been found in humans to
be significantly increased in the inflamed colon of CD patients.117
A unique Th17 subset that co-expresses IL-17 and IFNγ has also
been identified in the inflamed colon, but not in the peripheral
blood, of CD patients118 and a pathogenic role of IL-17 has been
demonstrated in some CD models.119,120 These findings highlight
the significance of Th17 subsets in CD, although it is unclear
whether autophagy plays a common or distinct role in these functionally different T cell subsets.
However, recent evidence has linked autophagy to the production of, and response to, key cytokines, and therefore opened the
possibility that some of the immune dysregulation observed in
IBD may result from aberrant autophagic processes. There is also
evidence that autophagy is affected by the cytokine environment,
with Th2 cytokines diminishing the ability of macrophages to
mount an effective anti-tuberculosis autophagic response.121
Recent research has highlighted the finding that cytokine
secretion is altered in both CD and the tumor microenvironment.

Following bacterial exposure, macrophages from CD patients
appear to deliver a large proportion of pro-inflammatory cytokines to the lysosomal system, rather than the appropriate secretory pathway.122 This results in reduced bacterial clearance and
therefore delays in dealing with infectious insults, potentially
leading to increased ongoing inflammatory responses. This failure to secrete adequate levels of cytokines is reminiscent of the
Paneth cell phenotype observed in mouse models and human
patients with defects in Atg16L1 or other autophagy genes,123,124
where mucin and cryptidin secretion are compromised. It will be
crucial to determine whether there are other secretory defects in
patients with polymorphisms within autophagy genes.
In the tumor microenvironment, high levels of CCL2 and
IL-6 have been observed to drive production of a tumor-promoting macrophage subset, termed M2.125 This polarization
occurs as a result of inhibition of apoptosis, via upregulation of
autophagy and inhibition of caspase activation, in myeloid cells
recruited to the tumor. Thus, autophagy is involved in profound
cellular changes in response to cytokines and the impact of defective autophagy upon cytokine signaling in specific cell types is
just beginning to be explored.
A major lymphocyte population in the mucosal immune compartment is B cells, with over 80% of activated B cells located
within mucosal tissues.126 As compared to T cells, B cells have
not typically been considered to be a major source of cytokines.
However, it is becoming increasingly apparent that, like T cells,
B cells also produce a wide array of cytokines, particularly under
inflammatory conditions.127,128 Intestinal inflammatory conditions induce the development of an IL-10-producing regulatory
B cell subset termed Bregs, which contribute to improving the
ongoing colitis seen in several IBD models.128 This concept of
Bregs, which arose from animal models of IBD, is supported by
recent case reports showing an exacerbation/development of UC
and a reduction of IL-10 production after B cell depletion therapy
using humanized mouse anti-human CD20 monoclonal antibody
(rituximab).129,130 The intestine contains a unique IgM+ B2 B cell
subset that is characterized by very high expression of MHC class
II.131 This B cell subset develops in an antigen-independent manner, and significantly expands in the context of inflammation and
contributes to host defense against enteric microorganisms by
producing IL-12p70. Peritoneal B1 B cells that produce natural
IgM against enteric microorganisms have an ability to suppress
the development of colitis,132 and their homeostasis is known to
be Atg5 dependent.133 Despite the role of autophagy in MHC
class II antigen presentation and a known role for Atg5 B cell
development and homeostasis, the effect of perturbed autophagy
upon B cell repertoires is still largely unknown.
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Intestinal Barrier Function and Oral Tolerance
The epithelium of the small intestine and colon create a complex, dynamic chemical and physical barrier between host and
microbes, the importance of which is underlined by results from
recent human genetic studies as well as data from established
model systems. Ideas that have emerged from such studies in
model experimental systems are increasingly being translated
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into human IBD utilizing genotyped patient material. From this
growing body of work, functional disease targets of the mucosal
barrier have been identified in specific epithelial cell types of the
gut. This portion of this review will highlight some of the recent
work in this area and the role autophagy plays in maintaining
barrier function and oral tolerance.
The chemical barrier I: mucus-producing goblet cells. The
first line of defense is a layer of mucus that is produced by specialized cells within the lining of the epithelium called goblet cells.
These cells are designed to store mucus for rapid exocytosis. The
most abundant mucus components, and the main component
of mucus in the intestine, is the Muc family of glycoproteins;134
Muc2 being the most common in the colon,135 although the
expression pattern of related gene products varies with location
along the proximal to distal intestinal axis.
Mucus is stored in discrete mucin secretory granules (MSGs)
that typically undergo merocrine secretion, a process by which
discharge of an individual granule occurs without the loss of any
part of the apical portion of the cell. This is a rapid process; typically a single granule is secreted within minutes of the application
of a given stimulus. A variety of physiological stimuli are known
to cause MSG secretion (reviewed in ref. 134 and 136) and
include autonomic nerve stimulation (cholinergic), substance P,
prostaglandins and ATP/UTP. The latter stimuli bind purinergic
receptors on the apical surface of goblet cells. These G-coupled
receptors also regulate fluid secretion (e.g., Cl- ions), and PDGF
is another known agonist. Neutrophil elastase also has non-receptor-mediated effects on goblet cells to stimulate MSG secretion.
Since much of our knowledge is based upon lung derived cells, it
will be important to perform studies on mouse and human goblet cells derived from the small intestine and colon to determine
the unique properties of goblet cells in this organ. A few human
goblet cell lines that are derived from adenocarcinomas have been
useful.137 Also, perhaps now the opportunity exists to maintain
explants or isolated epithelial cells in culture for studies on nontransformed cells.138,139
The importance of mucin production in the intestine is evidenced by studies of mutant mice that lack the main component
of colonic goblet cell mucus, Muc2.140,141 These mice contain
decreased lumenal mucus and over time develop spontaneous
colitis and epithelial tumors. The enhanced susceptibility to
injury of Muc2 deficient mice can be further evoked either by
treatment with dextran sodium sulfate or by breeding into an
IL-10 knockout background.142,143 Interestingly, the loss of function of other genes such as Mmp9 creates an increased susceptibility to damage by ultimately causing a decrease in Muc2 and,
thus, mucus production.144 One proposed mechanism by which
loss of mucus creates inflammation is that the indigenous colonic
microbes gain direct access to the surface epithelium.145 The
Muc2 model, while not a known genetic correlate to human CD,
is an instructive model for the importance of the mucus barrier.
Goblet cells also preferentially express other genes that, when
knocked-out result in mice with greater susceptibility to gut
injury. These include: resistin-like-beta (Relmβ), which has been
proposed to augment mucus secretion from goblet cells in an
autocrine fashion as well as to stimulate CD4 + T cells to produce

cytokines,146-149 and Trefoil factor 3 (TFF3) produced by goblet
cells in response to TLR2 signaling and a critical downstream factor of this signaling pathway.150 The lack of production of TFF3
appears to be a feature of the intestinal mucosa in UC patients
that carry a polymorphism within TLR2 (R753Q151). Future
work in both mouse models and human patient material analysis
should further determine if specific IBD susceptibility alleles can
affect goblet cell differentiation and/or mucus secretion.
The chemical barrier II: antimicrobial protein-producing
Paneth cells. Mucus alone is not a sufficient chemical barrier as many members of the intestinal microbiota contain an
abundance of glycosyl hydrolases,152 thus rendering mucus an
attractive potential energy source for specific members of the
microbiota. However, the mucus layer is an important repository
for immunoglobulins (e.g., IgA) and a variety of antimicrobial
peptides produced by the intestinal epithelium.
In the small intestine, the primary, but not exclusive, source
of antimicrobial proteins and peptides is Paneth cells. Their
main job is to produce, package and export a variety of antimicrobial proteins/peptides including multiple α-defensins (e.g.,
cryptdins), angiogenin-4, lysozyme and secretory phospholipase
A2.153,154 These proteins can alter the composition and abundance of individual species of indigenous microbes and appear
to play a role in the clearance of pathogens. As an example, mice
engineered to overexpress a human cryptdin were less susceptible to death when orally infected with high doses of Salmonella
typhimurium.155 These secretory functions may be directly related
to IBD since mice with an engineered loss of function for Atg16L1
contain Paneth cells that do not properly package antimicrobial
proteins into granules and secrete them into the lumen of the
intestine.123,124 This defect appears to be the result of the loss of
autophagy since loss of function of Atg5 and Atg7 in the intestinal epithelium recapitulates the Paneth cell phenotype observed
in the Atg16L1-deficient mice. In addition, Atg16L1 deficient
Paneth cells contain a gain of function whereby they express
increased levels of inflammatory cytokines such as adiponectin
and leptin. Humans with CD who carry the point mutation in
ATG16L1 corresponding to one of the susceptibility alleles for
this disease showed similar loss and gain-of-function defects in
their Paneth cells as those observed in the mouse model. Mice
with loss of function of another CD susceptibility gene, the ER
stress response gene Xbp1, contain Paneth cells that appear to
undergo premature apoptosis.156 Loss of function of yet another
CD susceptibility gene, the MDP receptor Nod2 may play a role
in diminished defensin production in Paneth cells, though this
result is controversial.157,158 Another link between Paneth cell
development and CD susceptibility is the presence of polymorphisms in the Tcf4 promoter.159 Partial loss of function of this
gene is related to diminished antimicrobial protein expression.160
Finally, it has been hypothesized that Paneth cells are a source
of growth factors, and recent data indicates that this role may
be responsive to the bacterial flora. Some intestinal resident
microbes such as B. thetaiotaomicron can stimulate Paneth cells
to produce mRNAs encoding the antimicrobial protein, angiogenin-4.161 This microbe can also stimulate angiogenesis in the
mesenchyme of small intestinal villi indirectly through Paneth
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cells by an as yet unknown mechanism.162 Paneth cells also produce inflammatory cytokines in both a constitutive (TNFα163)
and inducible fashion during injury (e.g., IL-17,164). However, the
functional significance of Paneth cell cytokine or growth factor
production has still not been tested experimentally.
Clearly, additional studies of Paneth cell function concerning
the impact of loss of function (diminished production or delivery
of antimicrobial proteins) on the intestinal microbiota and gain
of function (increased inflammatory cytokine production) on
the mucosal immune system will be critical in the future. Also,
understanding the triggers of Paneth cell malfunction (if any) in
a genetically susceptible host will be important aspects of IBD
pathogenesis.
The cellular barrier: enterocytes. Underlying the mucus
layer is a physical barrier that is created primarily by absorptive
enterocytes that dominate the epithelium, lining villi in the small
intestine and pericryptal cuffs in the colon. The intestinal epithelium is a dynamic barrier in which tightly bound epithelial cells
are renewed by accelerated division of crypt cells that migrate
upwards from the bottom of intestinal crypts. It is also a highly
interactive barrier able to mount rapid responses to pathogens
through the production of antimicrobial proteins and mobilization of neutrophils and, through collaborations with antigen
presenting cells, induce mucosal adaptive immune responses.165
In the small intestine, four differentiated lineages are produced:
absorptive enterocytes, goblet cells, hormone secreting enteroendocrine cells and Paneth cells. All of these lineages except Paneth
cells migrate out of crypts onto the surfaces of mucosal evaginations into the lumen called villi, migrating to the villus tip over a
period of 3–5 days. Conversely, Paneth cells migrate to the base of
crypts where they intermingle with epithelial stem cells and have
a much longer life span (at least 30 days). The colon contains the
same basic organization of the epithelium with the two notable
exceptions that instead of villi, epithelial cells migrate out of each
crypt onto a flat surface cuff that surrounds each crypt opening
and there are no Paneth cells. The exception to the latter feature
is in the proximal portion of the inflamed human colon where
the presence of Paneth cells is considered to be metaplastic.166
A critical component of the barrier function of the surface
epithelium is the apical junctional complex that consists of tight
and adherens junctions; for example overexpression of the myosin light chain kinase in the intestinal epithelium leads to tight
junction dysfunction and ultimately broad activation of mucosal immune responses.167 The function of tight junctions in the
control of permeability is particularly sensitive to inflammatory
cytokines such as tumor necrosis factor. Interestingly, specific
pathogens such as enteropathogenic E. coli disrupt tight junctions to increase permeability.168 This pathogen also targets the
function of sodium absorption through inhibition of the sodium
hydrogen exchanger 3.169 Mice with loss of function of this gene
develop spontaneous colitis,170 suggesting an important immuneregulatory function for this ion transporter.
Cytoskeletal alterations can also affect the ability of enterocytes to create an effective barrier. Loss of function of keratins
does not appear to cause a defect in handling mechanical stress,
but instead affects permeability and subsequent Th2 T cell

activation.171 Loss of function of the three Vav GTPases leads to
diminished microtubule networks in colonic enterocytes resulting in shortened cells. In combination with immune defects in
the Vav knockout mice, this results in a spontaneous breakdown
of the colonic intestinal barrier and focal ulceration.
These studies lay the groundwork for potential mechanisms
by which enterocytes could be defective in IBD. It will be interesting in the future to see how specific susceptibility genes fit into
these pathways. For example, mice with loss of STAT3 function
in the intestinal epithelium exhibit worse damage upon dextran
sodium sulfate treatment and greater numbers of tumors upon
addition of azoxymethane.172 A key question in moving forward
is whether these human susceptibility alleles are additive, particularly with regard to the different aspects of barrier function
such as chemical, physical, cellular and immune.
Oral tolerance. Oral tolerance has been described in most
monogastric mammals, including humans.173 A vast range of
antigens can be used to suppress all aspects of systemic immune
responses when administered orally, although most of these share
the property of being inert and/or soluble thymus-dependent
antigens, such as proteins. Generally, T cell-mediated responses
and tissue immunopathology are very sensitive to low doses of
orally administered antigens. By contrast, antibody responses are
less easily inhibited, and the status of local IgA responses in oral
tolerance and whether or not they are suppressed as a result of
orally administerting antigen are still unclear. Despite its profound effects on systemic immunity and its practical and clinical importance, the mechanisms responsible for oral tolerance
remain elusive.
Mechanisms of oral tolerance. Using very different in vitro or
in vivo approaches, immune tolerance can occur through active
suppression, anergy or apoptosis of (self) antigen-reactive lymphocytes. However, no clear consensus has been reached about
the relative importance or contribution of each of these. Indeed
it is possible that there is a wide range of different regulatory
mechanisms that may either be important under different circumstances or that collectively are needed to ensure systemic tolerance.174 The question of whether tolerance to the antigens of
the microbiota exists is unanswered, although some data suggests
that this is the case. For example, the absence or diminishment of
antibody responses in animals systemically administered indigenous gut bacteria,175,176 differences in immunogenicity of different members of the microbiota177 and the finding that normal
individuals are tolerant to their own microbiota, whereas they
respond to bacteria of others with a breakdown of tolerance to
antigens of an individuals own microbiota, resulting in IBD.178
Oral tolerance and intestinal epithelial cells. Intestinal epithelial cells (IECs) possess many of the attributes of professional
APCs including their ability to sample soluble proteins via nonselective (fluid-phase pinocytosis) and selective receptor-mediated routes179,180 and express MHC class I and II molecules.181,182
However, as IECs normally lack expression of the co-stimulatory
molecules required for full T cell activation,183 they are good candidates for tolerogenic antigen presenting cells in vivo. This may
not, however, be the only mechanism by which IECs can control and suppress mucosal T cell responses. For example, primary
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colonic epithelial cells, some of which express co-stimulatory
molecules, are still effective at suppressing CD4 + T cell activation by professional APCs.184 IECs are also a source of immunosuppressive cytokines such as TGFβ.185 By a variety of means,
therefore, IECs can exert the global hypo-responsiveness that is
characteristic of oral tolerance with the dysregulation of any of
their pathways of suppression able to contribute to the uncontrolled inflammation seen in IBD.
One way in which IEC ability to induce or preserve mucosal
T cell tolerance would be compromised is through perturbations
in the processing and presentation of self antigens. Several lines
of evidence suggest that autophagy pathways might be involved
in intracellular antigen processing for MHC class II loading and
considerable levels of autophagy have been observed in thymic
epithelial cells and immature dendritic cells involved in central and peripheral T cell tolerance induction, respectively.102,104
Second, the activation of autophagy that invariably follows
microbial infection has the potential to increase processing of
host, microbial and dietary antigens by MHC class II pathways,
and this may alter the spectrum of peptides presented to the
immune system.
Activation of autophagy by bacteria. It has become clear that
despite different intracellular niches, diverse bacterial pathogens
can be engulfed by autophagosomes and delivered to lysosomes.
Thus, autophagy acts as a defense against bacteria that are unable
to tolerate lysosomes, and for these bacteria activation of autophagy results in microbial degradation, increased class II antigen presentation and decreased microbial yields. Bacteria can,
however, survive if they are able to block autophagy or prevent
delivery to lysosomes. Most Salmonella remain within modified
phagosomes called Salmonella-containing vacuoles (SCV) and
are unaffected by autophagy. Damage to the SCVs or release
of bacteria into the cytosol, results in engulfment by autophagosomes, delivery to lysosomes and bacterial destruction.186
Shigella flexneri resides within the host cytosol and secretes
the VirG protein that is required for actin-based motility and
transfer to neighboring cells. VirG binds to Atg5 and activates
autophagy, but virulent isolates survive because this interaction
is masked by the Shigella IcsB protein.187 Listeria monocytogenes
evades autophagosomes via ActA-dependent actin-based motility
and by secreting bacterial phospholipases that may compromise
the autophagosome membrane.188,189 Other bacteria have evolved
to replicate in the lysosome, and in these cases bacteria may even
activate autophagy to accelerate delivery to lysosomes, as seen for
example with Coxiella burnetii.190 Francisella tularensis disrupt the
phagosome membrane soon after cell entry and are engulfed by
autophagosomes and delivered to lysosomes. Francisella tularensis
is, however, resistant to degradation in lysosomes and activation
of autophagy increases microbial replication.191 Thus, autophagy
can protect the cell cytosol from infection, but is also subverted
by specialized pathogens via specific virulence factors.
Activation of autophagy by viruses. Much of what we know
about autophagy and viral infection comes from studies on herpes simplex virus where inhibition of autophagy by the viral
ICP34.5 protein leads to neurovirulence192 and from studies of
the positive-stranded RNA viruses such as picornaviruses and

coronaviruses, which induce double-membrane vesicles for use as
platforms for replication.193-195 There are no examples of intestinal infection by human coronaviruses viruses and the role played
by autophagy during cornavirus replication has recently become
controversial.196,197 Picornaviruses such as poliovirus and coxsackieviruses do, however, replicate in gastrointestinal epithelial
cells and induce LC3 processing and translocation of GFP-LC3
from the cytosol to autophagosomes in cell culture models.198,199
Poliovirus replicase proteins co-localize with LC3 suggesting that
replication takes place on autophagosomes, and assembly of the
replicase complex may be provide the signal that activates autophagy.198 Replicase protein 2BC alone causes conversion of LC3-I
to LC3-II and recruitment of LC3 to membranes, but co-expression of poliovirus 3A and 2BC replicase proteins is required to
convert these membranes into double-membraned vesicles resembling autophagosomes that stain for LC3 and LAMP-1.200,201
Similarly, infection of IPCs by rotaviruses, which cause viral gastroenteritis, results in recruitment of LC3 to virus-induced membranes,202 again providing a link between viral infection of IPCs
and activation of autophagy. Since our knowledge of the human
virome is still nascent,203,204 it will be of great interest to observe
whether specific intestine-tropic viruses are identified as being
associated with gut inflammation and perhaps inducing chronic
inflammatory states in susceptible individuals. In a recently published study in a mouse model of Atg16L-deficient mice, investigators found that the persistent infection of a common enteric
virus in mouse colonies, murine norovirus, is required to trigger abnormal Paneth cell secretion and responses to DSS toxin
injury. Interestingly, autophagy function is not responsible for
differences in innate immunity and does not play a role in the
clearance of the virus. Instead, Atg16L1 function is required
for the proper function of specific epithelial host cell types in
response to this persistent infection. Thus, this study is a specific
virus-plus-susceptibility gene interaction in the context of CD.
Pattern recognition during phagocytosis by antigen-presenting cells. Autophagy can also be activated from outside
the cell following recognition of PAMPS by Toll-like receptors (TLRs). This makes it possible that constant exposure to
gut microbiota could deliver sustained activation autophagy of
gastrointestinal APCs and other cells with TLR receptors. A
screen for PAMPS able to activate autophagy through TLRs of
phagocytic cells has shown potent activation following recognition of single stranded RNA by TLR7.81 TLR7 is mostly confined to endocytic compartments and provides a defense against
viral infection, as demonstrated by activation of plasmacytoid
dendritic cells by TLR7 signaling during infection by vesicular
stomatitis virus.76,205 Induction of autophagy by TLR7 ligands
requires the MyD88 adaptor protein and activation may be
mediated through displacement of Beclin 1 from Bcl-2 following
binding of Beclin 1 to MyD88 and TRIF.206 Beclin 1 may also be
released from Bcl-2 during TLR signaling following phosphorylation by JNK.207 Activation of autophagy by TLR7 accelerates
elimination of Mycobacteria from macrophages81 showing that
activation of TLR7 during viral infection can affect the outcome
of bacterial infection. Bacterial products such as LPS have also
been shown to activate autophagy via TLR4.82 TLR4 induction
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of autophagy requires class III PtdIns 3-kinases and p38 MAPK.
TLR4 signaling also upregulates LRG47 GTPase, and in common with TLR7, increases elimination of Mycobacteria from
macrophages.82
Activation of autophagy following TLR signaling from
phagosomes has also been studied using TLR ligands immobilized on latex beads.77 Beads bound to synthetic bacterial
lipopeptides (Pam3CSK4, TLR1/2), zymosan (TLR2) or LPS
(TLR4) stimulate autophagy and caused rapid recruitment of
Beclin 1, PtdIns 3-kinase activity and LC3 to the phagosome
membrane. Recruitment is dependent on Atg5 and Atg7, and
results in increased fusion of LC3 with lysosomes; even so it was
not possible to detect double-membraned vesicles associated with
phagosomes. This makes it possible that TLR signaling results
in direct recruitment of LC3 and PtdIns 3-kinase activity from
the cytosol to the phagosome membrane to facilitate fusion with
lysosomes to enhance elimination of incoming microorganisms.
This may also be the case for Nod2, indicating that autophagy
may be a general response to PAMP-derived signals that serves as
an anti-infection mechanism.
The Microbial Hypothesis of IBD

mucosa 217 and that increased numbers of E. coli are associated
with the epithelial intestinal layer.219,222-224 Phenotypic characterization of CD-associated E. coli, which are AIEC, shows that
they are able to adhere to and invade intestinal epithelial cells,
but also to survive and replicate within macrophages, leading
to the secretion of high amounts of TNFα.225,226 Such invasive
E. coli have been observed by many groups in Europe and the
United States.222,227-231 Like other pathogenic E. coli strains,
AIEC are potent pro-inflammatory inducers since the interaction between bacteria and host cells activates several pathways
which lead to NFκB activation, upregulated IL-8 expression
and transmigration of polymorphonuclear leukocytes.228,232 This
inflammatory response is thought to result from the interaction
of flagellin with Toll-like receptor 5 (TLR5) and IPAF,233 but the
roles of the NOD family are yet to be fully elucidated in these
models. In contrast to many pathogens that escape from the normal endocytic pathway, CD-associated invasive E. coli are taken
up by macrophages within phagosomes, which mature without
diverting from the classical endocytic pathway and which share
features with phagolysosomes.234 Because of their ability to survive and replicate within epithelial cells, we could hypothesize
that these pathogenic bacteria possess mechanisms to circumvent
the innate host response and survive under hostile intracellular
conditions. So far, such factors have yet to be identified in AIEC,
since these organisms lack canonical type III secretion for delivery of effector proteins to host cells. This is in contrast to Shigella
spp. which shares a similar lifestyle within the host epithelium
and for which virulence factors required for autophagy avoidance have been identified.187 Further investigations are needed
to determine whether AIEC can escape from or modulate autophagy in order to survive and/or replicate and whether they could
replicate at a higher level in host cells with altered autophagy.
Recent data suggest that AIEC are subject to autophagic control within epithelial cells, and that this process is influenced by
ATG16L1 genotype.235
Despite these findings, it remains unclear whether such alterations in flora represent a proximal cause of inflammation, or are a
consequence of disease. Such inflammation-induced shifts in the
gut flora have been observed following infection in mouse models, with both Citrobacter rodentium and Salmonella typhimurium
infection promoting growth of Enterobacteriaceae.236,237
E. coli overgrowth could also be due to abnormal expression
of host molecules acting as receptors for bacterial adhesion. In
CD patients with ileal involvement of the disease, Barnich et
al. recently observed an abnormal ileal expression of carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6)
and showed that CEACAM6 acts as a very efficient receptor mediating binding of pathogenic CD-associated E. coli.238
Interestingly, in vitro studies demonstrate that CEACAM6
expression is increased in cultured intestinal epithelial cells not
only after IFNγ or TNFα stimulation,239 but also after infection
with AIEC bacteria, indicating that AIEC bacteria can promote
their own colonization in CD patients.238 In addition, using the
transgenic CEABAC10 mice expressing human CEACAM6,240
the Darfeuille-Michaud laboratory showed that CD-associated
AIEC bacteria can colonize the intestinal mucosa and induce gut
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CD has several features reminiscent of a microbial or infectious
process in the gut114,208,209 and this has led many investigations into
finding the potential infectious agent responsible. Mycobacterium
avium subspecies paratuberculosis (MAP) was perhaps the bacterium with the longest history as a putative pathogenic role in
CD.210,211 MAP had been initially favored as a candidate pathogen because there are clinical similarities between Johne disease,
a spontaneous MAP infection in ruminants and CD. In the past
few decades, several dozen published studies have provided evidence that both supports and disputes the association of MAP
with CD.210,212,213 However there remains no direct evidence that
MAP plays a causal role in human CD and despite the establishment of culture-free molecular tools for microbial identification,
MAP has not been observed in the majority of CD or IBD cases.
Similar cases have been made for other putative IBD-associated
pathogens, including Listeria monocytogenes and Yersinia spp.,
but again evidence has been lacking, despite some circumstantial
observations.214-216
What has become evident is that IBD patients exhibit an
intestinal dysbiosis (microbial imbalance)—studies of lumenal
bacterial composition in patients with IBD using both culture
and molecular biological techniques have provided evidence
for a decrease in beneficial bacteria such as the Bifidobacteria,
Lactobacilli and Firmicutes and an increase in putative pathogenic bacteria such as Bacteroides and Escherichia coli.217-220 This
dysbiosis may promote inflammation by inducing a breakdown
in the balance between putative protective versus harmful intestinal bacteria. Indeed, a recent study showed that a low proportion
of Faecalibacterium prausnitzii, bacteria with high anti-inflammatory properties, is associated with endoscopic recurrence at
6 months on resected ileal Crohn mucosa.221 In addition, various studies in CD patients reported that high concentrations of
bacteria forming a biofilm are found on the surface of the gut
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inflammation (Carvalho et al. manuscript submitted). Perhaps
some of these questions may be answered in longitudinal metagenomic studies of large cohorts, but such efforts are only just getting underway.
The implication of the Nod2-autophagy-innate immune axis
through genetic studies have strengthened the idea that AIEC,
but also other as-yet unidentified microbes such as enteric viruses,
could be candidates for a role in CD. The basis of these assumptions rests upon the imputed host genetic susceptibility due to
impaired function in host defense against intracellular bacteria,
induced by polymorphisms in pathogen sensing and innate effector systems, such as Nod2 and autophagy.
Despite years of study, bacterial/CD correlations in humans
have not yet approached fulfilling Hill’s criteria for causation;241
however, recent work demonstrating norovirus-autophagy interactions in an Atg16L1-hypomorphic mouse model of IBD shows
promise in beginning to define specific pathogenic interactions in
susceptible hosts.242 With current high-throughput technologies
and large, genotyped patient cohorts it may be possible to identify putative initiating agents for further testing. Studies using
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